Evidence map›Paper›PMID 37646886›Full record

ArticleApplied biochemistry and biotechnology2024

High Drug Capacity of Nano-Levodopa-Liposomes: Preparation, In Vitro Release and Brain-Targeted Research.

Shenna Chen, Lin Wang, Yue Hu, Sha Liu, Lina Geng, Yayong Li

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shenna ChenCollege of Chemistry and Material Science, Hebei Key Laboratory of Organic Functional Molecules, Hebei Normal University, Shijiazhuang, 050024, China.ORCID http://orcid.org/0000-0002-8768-7049
Lin WangCollege of Chemistry and Material Science, Hebei Key Laboratory of Organic Functional Molecules, Hebei Normal University, Shijiazhuang, 050024, China.
Yue HuCollege of Chemistry and Material Science, Hebei Key Laboratory of Organic Functional Molecules, Hebei Normal University, Shijiazhuang, 050024, China.
Sha LiuCollege of Chemistry and Material Science, Hebei Key Laboratory of Organic Functional Molecules, Hebei Normal University, Shijiazhuang, 050024, China.
Lina GengCollege of Chemistry and Material Science, Hebei Key Laboratory of Organic Functional Molecules, Hebei Normal University, Shijiazhuang, 050024, China. genglina0102@126.com.ORCID http://orcid.org/0000-0002-2735-6061
Yayong LiDepartment of Rehabilitation Medicine, Shijiazhuang People's Hospital, Shijiazhuang, 050000, China.

Funding

National Natural Science Foundation of China 31201305Natural Science Foundation of Hebei Province B2019205054Natural Science Foundation of Hebei Province B2021205001Natural Science Foundation of Hebei Province E2022205011Science Foundation of Hebei Normal University L2023J01Teaching Reform project of Hebei Normal University 2021XJJG047
6 · The paper itself

Abstract

In this work, nano-levodopa-liposomes (L-dopa-Lip) suspension was prepared by rotary-evaporated film-ultrasonic method, and freeze-drying powders of L-dopa-Lip were also obtained to improve the stability. The products were characterized by TEM, DLS, and TG-DSC, and the phase-transition temperature (T

Indexed as

BrainLevodopaLiposomesAnimalsDrug Delivery SystemsDrug LiberationGoldMetal NanoparticlesGoldLevodopaLiposomesAuNPsL-dopaLiposomeParkinson’s diseaseThe central nervous system

Identifiers

PMID37646886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.